236 related articles for article (PubMed ID: 19419812)
1. Shikonin, an ingredient of Lithospermum erythrorhizon, down-regulates the expression of steroid sulfatase genes in breast cancer cells.
Zhang Y; Qian RQ; Li PP
Cancer Lett; 2009 Oct; 284(1):47-54. PubMed ID: 19419812
[TBL] [Abstract][Full Text] [Related]
2. Shu-Gan-Liang-Xue Decoction, a Chinese herbal formula, down-regulates the expression of steroid sulfatase genes in human breast carcinoma MCF-7 cells.
Zhang Y; Li PP
J Ethnopharmacol; 2010 Feb; 127(3):620-4. PubMed ID: 20015473
[TBL] [Abstract][Full Text] [Related]
3. The role of STS and OATP-B mRNA expression in predicting the clinical outcome in human breast cancer.
Al Sarakbi W; Mokbel R; Salhab M; Jiang WG; Reed MJ; Mokbel K
Anticancer Res; 2006; 26(6C):4985-90. PubMed ID: 17214375
[TBL] [Abstract][Full Text] [Related]
4. Differential effect of hormone therapy on E1S-sulfatase activity in non-malignant and cancerous breast cells in vitro.
Stute P; Götte M; Kiesel L
Breast Cancer Res Treat; 2008 Apr; 108(3):363-74. PubMed ID: 17546497
[TBL] [Abstract][Full Text] [Related]
5. Assessment of shikonin for potential estrogenic activity by dual-luciferase reporter based bioluminescent measurements in vitro.
Zhang Y; Li PP
Pharmazie; 2011 Feb; 66(2):141-3. PubMed ID: 21434578
[TBL] [Abstract][Full Text] [Related]
6. Quantitative analysis of aromatase, sulfatase and 17beta-HSD(1) mRNA expression in soft tissue metastases of breast cancer.
Irahara N; Miyoshi Y; Taguchi T; Tamaki Y; Noguchi S
Cancer Lett; 2006 Nov; 243(1):23-31. PubMed ID: 16556483
[TBL] [Abstract][Full Text] [Related]
7. In vivo efficacy of STX213, a second-generation steroid sulfatase inhibitor, for hormone-dependent breast cancer therapy.
Foster PA; Newman SP; Chander SK; Stengel C; Jhalli R; Woo LL; Potter BV; Reed MJ; Purohit A
Clin Cancer Res; 2006 Sep; 12(18):5543-9. PubMed ID: 17000691
[TBL] [Abstract][Full Text] [Related]
8. Strong expression of steroid sulfatase in human cumulus cells in patients with endometriosis.
Yanaihara A; Otsuka Y; Iwasaki S; Okai T; Yanaihara T
Fertil Steril; 2005 Aug; 84(2):464-7. PubMed ID: 16084891
[TBL] [Abstract][Full Text] [Related]
9. A new therapeutic strategy against hormone-dependent breast cancer: the preclinical development of a dual aromatase and sulfatase inhibitor.
Foster PA; Chander SK; Newman SP; Woo LW; Sutcliffe OB; Bubert C; Zhou D; Chen S; Potter BV; Reed MJ; Purohit A
Clin Cancer Res; 2008 Oct; 14(20):6469-77. PubMed ID: 18927286
[TBL] [Abstract][Full Text] [Related]
10. [Shikonin down-regulates CXCR4 expression and inhibits CXCL12-induced migratory responses in colorectal carcinoma cell line SW480].
Wen ZF; Wei XQ; Guo YW; Zheng FP
Zhonghua Wei Chang Wai Ke Za Zhi; 2009 Nov; 12(6):627-9. PubMed ID: 19921580
[TBL] [Abstract][Full Text] [Related]
11. Analysis for localization of steroid sulfatase in human tissues.
Suzuki T; Miki Y; Fukuda T; Nakata T; Moriya T; Sasano H
Methods Enzymol; 2005; 400():303-16. PubMed ID: 16399357
[TBL] [Abstract][Full Text] [Related]
12. Human ACAT inhibitory effects of shikonin derivatives from Lithospermum erythrorhizon.
An S; Park YD; Paik YK; Jeong TS; Lee WS
Bioorg Med Chem Lett; 2007 Feb; 17(4):1112-6. PubMed ID: 17157006
[TBL] [Abstract][Full Text] [Related]
13. Shikonin, a constituent of Lithospermum erythrorhizon exhibits anti-allergic effects by suppressing orphan nuclear receptor Nr4a family gene expression as a new prototype of calcineurin inhibitors in mast cells.
Wang X; Hayashi S; Umezaki M; Yamamoto T; Kageyama-Yahara N; Kondo T; Kadowaki M
Chem Biol Interact; 2014 Dec; 224():117-27. PubMed ID: 25451590
[TBL] [Abstract][Full Text] [Related]
14. The development of steroid sulfatase inhibitors for hormone-dependent cancer therapy.
Day JM; Purohit A; Tutill HJ; Foster PA; Woo LW; Potter BV; Reed MJ
Ann N Y Acad Sci; 2009 Feb; 1155():80-7. PubMed ID: 19250195
[TBL] [Abstract][Full Text] [Related]
15. In vivo and in vitro expression of steroid-converting enzymes in human breast tumours: associations with interleukin-6.
Speirs V; Walton DS; Hall MC; Atkin SL
Br J Cancer; 1999 Oct; 81(4):690-5. PubMed ID: 10574257
[TBL] [Abstract][Full Text] [Related]
16. Shikonin, a natural product from the root of Lithospermum erythrorhizon, is a cytotoxic DNA-binding agent.
Chen C; Shanmugasundaram K; Rigby AC; Kung AL
Eur J Pharm Sci; 2013 Apr; 49(1):18-26. PubMed ID: 23422689
[TBL] [Abstract][Full Text] [Related]
17. Shikonin, an ingredient of Lithospermum erythrorhizon, inhibits angiogenesis in vivo and in vitro.
Hisa T; Kimura Y; Takada K; Suzuki F; Takigawa M
Anticancer Res; 1998; 18(2A):783-90. PubMed ID: 9615720
[TBL] [Abstract][Full Text] [Related]
18. Shikonin suppresses the migratory ability of hepatocellular carcinoma cells.
Wei PL; Tu CC; Chen CH; Ho YS; Wu CT; Su HY; Chen WY; Liu JJ; Chang YJ
J Agric Food Chem; 2013 Aug; 61(34):8191-7. PubMed ID: 23899086
[TBL] [Abstract][Full Text] [Related]
19. Steroid sulfatase in breast carcinoma and change of serum estrogens levels after operation.
Tsunoda Y; Shimizu Y; Tsunoda A; Takimoto M; Sakamoto MA; Kusano M
Acta Oncol; 2006; 45(5):584-9. PubMed ID: 16864173
[TBL] [Abstract][Full Text] [Related]
20. 2-phenylindole sulfamates: inhibitors of steroid sulfatase with antiproliferative activity in MCF-7 breast cancer cells.
Walter G; Liebl R; von Angerer E
J Steroid Biochem Mol Biol; 2004 Apr; 88(4-5):409-20. PubMed ID: 15145451
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
